Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3209 of 6351
-
Could a Parkinson's drug tame OCD?
Symptom relief OngoingThe primary aim of the present study is to examine the efficacy and safety of tolcapone in adults with moderate to severe OCD.
Phase 2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Virtual reality may protect young brains during cancer treatment
Symptom relief Recruiting nowThe objective of this study is to estimate the feasibility and acceptability of cognitive training in the virtual reality setting with children undergoing radiotherapy for brain tumors. To achieve this goal, the investigators plan to study children undergoing radiotherapy for bra…
Sponsor: St. Jude Children's Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can good bacteria beat bladder infections? new study investigates
Disease control OngoingUrinary tract infections (UTIs) are the most common bacterial infections in women. 50% of women experiencing at least one UTI in their lifetime with an annual prevalence of 0.5-0.7%. An interventional, randomized, double-blind, placebo-controlled study will be conducted to inves…
Sponsor: ProbiSearch SL • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Pacemaker upgrade aims to tame high blood pressure
Disease control Recruiting nowAfter meeting all inclusion/exclusion criteria, subjects on standard pacing with the Moderato® or Moderato Plus Implantable Pulse Generator (IPG) will be subjected to two set-up sessions for the CNT algorithm: at week 4 and at week 6 post implant. At the end of these visits, subj…
Sponsor: BackBeat Medical Inc • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a 3D image replace the wire in heart procedures?
Disease control OngoingTo test whether FFRangio-guided treatment is non-inferior to conventional pressure wire-guided treatment in patients with coronary artery disease.
Sponsor: CathWorks Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a phone app help teens cut back on marijuana? new study says maybe.
Disease control CompletedThe study is about helping teens who are involved in the court system to cut down or quit using marijuana. Teens may be asked to test out an experimental smartphone app, called TECH, that will be used only by teens in this study. This app is a private online community where teens…
Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New hope for advanced cancer: first human trial of FZ-AD004 begins
Disease control Recruiting nowThis study is one single group of participants with advanced solid tumors. It is the first time the drug has been used in humans. There will be two parts including Dose Escalation and Dose Expansion to evaluate the safety, tolerability, pharmacokinetics, and clinical activity of …
Phase 1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a walk in the park or a nature video boost your immune system?
Knowledge-focused CompletedRandomized clinical trial on the influence of intentional and indirect contact with nature on the immune response and affective states in people aged 50 years or older.
Sponsor: Hospital Israelita Albert Einstein • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
New drug combo shows promise for tough HPV cancers in early trial
Disease control CompletedThis is an open-label, non-randomized, Phase I, dose escalation/dose expansion study in cohorts of patients with relapsed, resistant, or metastatic HPV-associated cancers. The Expansion Phase will begin in parallel one dose level lower than the highest dose deemed safe in the Dos…
Phase 1 • Sponsor: Toragen, Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:24 UTC
-
New hope for tough blood cancers: experimental drug AC676 enters human testing
Disease control Recruiting nowThis clinical trial is evaluating a drug called AC676 in participants with Relapsed/Refractory B-cell Malignancies. The main goals of the study are to: * Identify the recommended dose of AC676 that can be given safely to participants * Evaluate the safety profile of AC676 * Eval…
Phase 1 • Sponsor: Accutar Biotechnology Inc • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Meditation app may ease pain after hysterectomy
Symptom relief CompletedThis is a randomized control trial investigating the effects of a preoperative mindfulness intervention on postoperative pain, quality of recovery and stress scores in women undergoing minimally invasive hysterectomy. The mindfulness intervention will be delivered via the applica…
Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New microscope could help surgeons spot hidden skin cancer in real time
Diagnosis CompletedThe goal of this clinical trial is to compare the use of two photon fluorescence microscopy for detecting residual basal cell carcinoma during Mohs surgery. The main question it aims to answer is: • How similar are diagnosis of surgical margins to on two photon fluorescence micr…
Sponsor: University of Rochester • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
Free produce program shows promise for diabetes patients facing food insecurity
Disease control CompletedThe goal of this clinical trial is to assess the impact of participation in Eat Well for diabetes patients who are at risk of food insecurity. The main questions it aims to answer are: * whether there is a difference in Haemoglobin (Hb) A1c measurements and emergency department …
Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Sip your way sharper? ketone drink tested against sleep loss
Symptom relief OngoingSleep deprivation is a major problem in military populations. Some major consequences of sleep loss are inability to concentrate, poor work efficiency, and increase in errors during daily tasks. There is some evidence that ketone ester supplements may lessen the adverse effects o…
Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Tiny implant beams heart data from inside the body
Disease control OngoingEarly Feasibility Study of the NORM™ System in Heart Failure Patients
Sponsor: Foundry Innovation & Research 1, Limited (FIRE1) • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New study aims to predict immunotherapy response in lung cancer patients before surgery
Knowledge-focused Recruiting nowNeoadjuvant immunotherapy has become the standard perioperative treatment in lung cancer, but its effective predictive biomarkers are lacking. A small cohort reported that homologous recombination deficiency (HRD) can be used as a reliable biomarker to predict the efficacy of neo…
Sponsor: Geneplus-Beijing Co. Ltd. • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New study aims to predict dangerous heart scarring in common valve condition
Knowledge-focused Recruiting nowThis is a multicenter, observational prospective and retrospective study which aims are: 1) to compute a scoring model potentially predictive for the diagnosis of fibrosis by CMR in patients with MVP; 2) to identify specific features that may predispose to ≥ mild VAs or SCD in pa…
Sponsor: Centro Cardiologico Monzino • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
New injection could shrink skin cancer before surgery
Disease control OngoingThis is a Phase 1b, single-center, open-label study, evaluating efficacy and safety of RP1 for the treatment of resectable cutaneous Squamous Cell Carcinoma in up to 12 evaluable patients. In this study, patients will receive RP1 via direct intratumoral (IT) injection into superf…
Phase 1/2 • Sponsor: Sherrif Ibrahim • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can a heart drug fix vessel damage in metabolic syndrome?
Disease control CompletedCoronary vascular dysfunction is one of the "final common pathways" for the impact of multiple cardiovascular risk factors. The investigators will conduct a randomized, double-blind placebo-controlled study in individuals with the metabolic syndrome and baseline coronary vascular…
Phase 2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
One shot wonder? new antibiotic trial for Kids' skin infections
Disease control CompletedThis protocol describes a randomized, open-label study to evaluate the safety and tolerability of 2 formulations of single-dose intravenous (IV) oritavancin diphosphate (Orbactiv and Kimyrsa) for the treatment of pediatric participants with acute bacterial skin and skin structure…
Phase 2 • Sponsor: Melinta Therapeutics, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC